Abstract
Epilepsy is a prevalent brain disorder, characterized by sudden, abnormal brain activity, making it difficult to live with. One-third of people with epilepsy do not respond to anti-epileptic drugs. Drug-resistant epilepsy is treated with brain surgery. Successful surgical treatment relies on identifying brain regions responsible for seizure onset, known as epileptogenic zones (EZ). Despite various methods for EZ estimation, evaluating their efficacy remains challenging due to a lack of ground truth for empirical data. To address this, we generated and evaluated a cohort of 30 virtual epilepsy patients, using patient-specific anatomical and functional data from 30 real drug-resistant epilepsy patients. This personalized modelling, based on the patient’s brain data, is called a virtual brain twin. For each virtual patient, we provided data that included anatomically parcellated brain regions, structural connectivity, reconstructed intracranial electrodes, simulated brain activity at both the brain region and electrode levels, and key parameters of the virtual brain twin. These key parameters, which include the EZ hypothesis, serve as the ground-truth for simulated brain activity. For each virtual brain twin, we generated synthetic spontaneous seizures, stimulation-induced seizures and interictal activity. We systematically evaluated these simulated brain signals by quantitatively comparing them against their corresponding empirical intracranial recordings. Simulated signals based on patient-specific EZ captured spatio-temporal seizure generation and propagation. Through in-silico exploration of stimulation parameters, we also demonstrated the role of patient-specific stimulation location and amplitude in reproducing empirically stimulated seizures. The virtual epileptic cohort is openly available, and can be directly used to systematically evaluate methods for the estimation of EZ or source localization using ground truth EZ parameters and source signals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the EU's Horizon Europe Programme SGA No.101147319 (EBRAINS 2.0), SGA No. 101137289 (Virtual Brain Twin), Amidex Recherche Blanc, No. AMX-22-RE-AB-135(HR-VEP).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used the data from 30 patients who underwent a standard presurgical protocol at La Timone Hospital in Marseille. Informed written consent was obtained in compliance with the ethical requirements of the Declaration of Helsinki and the study protocol was approved by the local Ethics Committee (Comite de Protection des Personnes sud Mediterranee 1). The data were strictly used to generate and evaluate synthetic data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work, that is, the virtual epileptic patient cohort, is available online at: https://search.kg.ebrains.eu/live/c1702a5b-bc8f-486e-a0ee-4758a707ff00
https://search.kg.ebrains.eu/live/c1702a5b-bc8f-486e-a0ee-4758a707ff00
